Article looking at 2022/23 ONS data
https://www.sciencedirect.com/science/article/pii/S2666776223002211?via%3Dihub
OECD data:
https://stats.oecd.org/index.aspx?queryid=104676
Article was highlighted in YouTube video, (Dr Jon Campbell)
His view reading the article (though he won't say it out loud) seems to be that the vaccine is causing the deaths. I have no clue about whether that is likely or not (and I am a fully paid up member of the vaccine club), however it does seem that if there is such a marked increaase in excess death worldwide investigating further seems prudent to find out what the actual causes are, whether vaccine or failing NHS, or lazy population since covid, or whatever.
From article:
"Excess deaths in 2022, 52,514 (9.26%)
This persisted into 2023 with 8.6% or 28,024 more deaths registered in the first six months of the year than expected.
OECD, UK, weeks 1 – 44, 2023
Excess deaths, 49,389 (9.44%)
The causes of these excess deaths are likely to be multiple and could include the direct effects of Covid-19 infection,
acute pressures on NHS acute services resulting in poorer outcomes from episodes of acute illness,
and disruption to chronic disease detection and management.
Further analysis by cause and by age- and sex-group may help quantify the relative contributions of these causes.
Office for Health Improvement and Disparities
3rd June 2022 to 30th June 2023
Excess deaths for all causes were relatively greatest for 50–64 year olds (15% higher than expected)
11% higher for 25–49 and under 25 year olds,
and about 9% higher for over 65s
Several causes
3rd June 2022–30th June 2023
All cardiovascular diseases, 12%
Heart failure, 20%
Ischaemic heart disease, 15%
Liver diseases, 19%
Acute respiratory infections, 14%
Diabetes, 13%
For middle-aged adults (50–64)
Cardiovascular diseases, 33% higher than expected
Ischaemic heart disease, 44%
Cerebrovascular disease, 40%
Heart failure 39% higher
Deaths involving acute respiratory infections, 43% higher
Diabetes, deaths were 35% higher
The pattern now is one of persisting excess deaths which are most prominent in relative terms in middle-aged and younger adults
Timely and granular analyses are needed to describe such trends and so to inform prevention and disease management efforts.
JP-S is Partner at Lane Clark & Peacock LLP, Chair of the Royal Society for Public Health and reports personal fees from Novo Nordisk and Pfizer Ltd outside of this submitted work."